Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fundación de investigación HM
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.